How Deep Blue Biotech is reprogramming bacteria to produce chemicals and eat CO2

In a world searching for sustainable alternatives to fossil fuel-derived products, Deep Blue Biotech – a graduate of climate-tech-focused fund Carbon13 ’s 2023 Venture Builder programme – is making waves with an innovative approach to chemical production. Using cyanobacteria – one of the most efficient photosynthetic organisms on the planet – they're developing technology that not only creates valuable chemicals for the personal care industry but removes CO2 from the atmosphere through the process. Tim Corcoran and Manuel Rios from Deep Blue Biotech sat down with us recently to talk through their groundbreaking work in synthetic biology, their business model, and their vision for a more sustainable future. Join me, your host, Tom Britton, Partner at SyndicateRoom as we dive into another episode of Antel Insights and explore this incredible startup and the work they are doing. Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. ⁠Take 2 mins to learn more⁠ .

You can listen to How Deep Blue Biotech is reprogramming bacteria to produce chemicals and eat CO2 online on Radio and Podcast. Open the player on this page to stream the available audio.

How Deep Blue Biotech is reprogramming bacteria to produce chemicals and eat CO2 is an episode from Angel Insights | Angel Investing | Crowdfunding by Angel Insights.

This episode is 00:27:44 long.

This episode was published on Apr 9, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Angel Insights | Angel Investing | Crowdfunding when more episodes are available from the podcast feed.